Palatin Gets US Patent to Use Melanocortin Peptides to Treat Immune System Dysregulation
Palatin Gets US Patent to Use Melanocortin Peptides to Treat Immune System Dysregulation
Palatin獲得美國專利,使用黑色素皮質素多肽治療免疫系統調節失調
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊